A股異動丨融捷股份漲停 簽訂8366萬元鋰精礦產品銷售合同
格隆匯12月31日丨融捷股份漲停,報25.67元,總市值66.65億元。公司近日公告稱,公司與廣東威華股份有限公司簽署了鋰輝石精礦購銷協議及補充協議,公司向交易對手方銷售鋰精礦產品,合同涉及金額為人民幣8366萬元(含税),若足額履行可實現營業收入約7404萬元,約佔公司2018年度經審計的營業總收入(合併報表)的19.34%。若該合同順利履行,將對公司2019年的經營業績產生較為積極的影響,具體影響金額以審計報告為準。此外,12月31日有2266.34萬限售股解除限售上市流通。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.